Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New sodium/glucose cotransporter 2 inhibitors developed in China

March 8, 2012

Madrigal launches new phase I trial of cholesterol-lowering agent

March 7, 2012

Advinus Therapeutics announces novel glucokinase activators

March 7, 2012

FDA issues complete response letter for ezetimibe/atorvastatin tablets

March 6, 2012

Savient launches named-patient program for gout therapy

March 6, 2012

Mitsubishi Tanabe and Daiichi Sankyo enter strategic alliance

March 6, 2012

Aegerion files applications for cholesterol-lowering agent in U.S. and E.U.

March 5, 2012

Arena Pharmaceuticals files MAA for weight control drug

March 5, 2012

FDA issues safety warning regarding statins

March 2, 2012

Amylin Pharmaceuticals presents novel glucagon GLP-1 receptor agonists

March 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...